FN Health
Menu
open
Clinical Trial Recruitment
The FDA just ended a 60-year standard. One trial is now the default. For biotech teams, that means every recruitment decision, every regulatory submission, and every site selection call carries more weight than ever before. FutureNova Health breaks down what changed, what it means for your pipeline, and why precision-first execution is no longer optional.
5
Feb 19, 2026
The FDA Just Changed a 60-Year Standard. Here's What Biotech Needs to Know
Other Articles
AI in 2026: What Healthcare Marketers Should Do After 2025’s Experiments
7
Feb 24, 2026
From Beer to Blood Tests: What the 2026 Super Bowl Reveals About Healthcare Marketing's New Era
8
Feb 8, 2026
FutureNova Unleashes Augmented Reality to Transform Healthcare Marketing Compliantly
Nov 6, 2025
Level Up Your Internal Communications: Four Ways NovaCore Transforms Year-End Deliverables
Oct 11, 2025
Where We've Been, Where We're Going
9
Dec 22, 2025
Why We're Publishing Our Pricing (And Why That's Uncomfortable)
Oct 6, 2025
Let's Connect
Full name
Email address
Message
Optional: Check box to subscribe to our marketing communications. You can unsubscribe at any time. Please review our Privacy Policy.
Send message
